首页> 外文期刊>Journal of Dispersion Science and Technology >Formulation and In Vitro Evaluation of Sustained Release Microspheres of Diltiazem Hydrochloride Prepared by Emulsification-Internal Gelation Method
【24h】

Formulation and In Vitro Evaluation of Sustained Release Microspheres of Diltiazem Hydrochloride Prepared by Emulsification-Internal Gelation Method

机译:乳化-内凝胶法制备盐酸地尔硫卓缓释微球的制备及体外评价

获取原文
获取原文并翻译 | 示例
       

摘要

The present work describes the formulation of alginate microspheres containing diltiazem hydrochloride by the emulsification-internal gelation method with the use of barium carbonate as a cross-linking agent. The effect of various factors (the concentration of alginate and barium chloride) on the drug loading efficiency and in vitro release were investigated. Fourier transform infrared microscopy (FTIR) and differential scanninig calorimetry (DSC) analysis confirmed the absence of any drug polymer interaction. X-ray diffraction (XRD) pattern showed that there is a decrease crystallinity of the drug. The in vitro drug release profile could be altered significantly by changing various processing parameters to give a controlled release of drug from microcapsules. The stability studies of drug-loaded microcapsules showed that the drug was stable at different storage conditions.
机译:本工作描述了使用碳酸钡作为交联剂通过乳化-内部凝胶化方法制备的包含盐酸地尔硫卓的藻酸盐微球的配方。研究了各种因素(藻酸盐和氯化钡的浓度)对载药效率和体外释放的影响。傅里叶变换红外显微镜(FTIR)和差示扫描量热法(DSC)分析证实不存在任何药物聚合物相互作用。 X射线衍射(XRD)图谱表明药物的结晶度降低。可以通过改变各种加工参数来使药物从微胶囊中受控释放,从而显着改变体外药物释放曲线。载药微胶囊的稳定性研究表明,该药物在不同的储存条件下是稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号